Published on 10 February 2021
Description:
What’s in store for rare genetic diseases in 2021, why we need to prove precision medicine is cost-effective, looking at the remote working revolution
Categories:
Pharmaceutical Market EuropePreview:
26 articles from this collection:
PME COVER
3 - Comment
4 - T40 2020 Edition
5 - Contents
6-7 - News
8-9 - Coronavirus news
10-11 - Coronavirus news
12 - Darwin’s medicine
13 - Rohit Khanna
14 - Mike Dixon
15 - A cultural shift in clinical research
16-17 - Rare genetic diseases
18-19 - New era for healthcare
18-19 - Pharma Market Europe New era for healthcare
20-21 - The promise of precision medicine
22-23 - Reaching patients and HCPs during the pandemic
24 - Research News
26-28 - The remote working revolution
29 - Lucid
30-32 - Back to the future
33-35 - Customer engagement
36-37 - Competitive intelligence
38-40 - Appointments
41 - Healthcare Comms News
42 - Q&A with Emily Spilko
43 - Recruitment
44 - Communiqué Awards 2021
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services